-+ 0.00%
-+ 0.00%
-+ 0.00%

NEOGENOMICS INC: SYNERGIES FROM TRANSACTION EXPECTED TO YIELD ANNUAL COST REDUCTIONS, WHICH WILL BE ACCRETIVE TO AEBITDA STARTING IN 2026

Reuters·03/10/2025 11:00:01

Please log in to view news